Transparency Market Research
Spinal Muscular Atrophy Phase 3 Candidate ISIS-SMNRx Expected to Reach USD 0.47 Billion in Sales in the U.S
20 oct. 2015 15h37 HE | Transparency Market Research
Albany - NY, Oct. 20, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research Spinal Muscular Atrophy Market: Pipeline Assessment, Size, Growth,...